CYFRA 21-1 as a Predictive Marker for Non-small Cell Lung Cancer Treated with Pemetrexed-based Chemotherapy

Pretreatment serum tumor marker levels predict outcome in non-small cell lung cancer (NSCLC). However, little is known about the clinical value of such measurements for patients treated with pemetrexed plus a platinum-derivative. We retrospectively screened 100 chemotherapy-naïve patients with advan...

Full description

Saved in:

Bibliographic Details
Published in:	Anticancer research Vol. 37; no. 2; pp. 935 - 940
Main Authors:	Sone, Kazuki, Oguri, Tetsuya, Nakao, Makoto, Kagawa, Yusuke, Kurowaka, Ryota, Furuta, Hiromi, Fukuda, Satoshi, Uemura, Takehiro, Takakuwa, Osamu, Kanemitsu, Yoshihiro, Ohkubo, Hirotsugu, Takemura, Masaya, Maeno, Ken, Ito, Yutaka, Sato, Hidefumi, Muramatsu, Hideki, Niimi, Akio
Format:	Journal Article
Language:	English
Published:	Greece 01-02-2017
Subjects:	Adult Aged Aged, 80 and over Antigens, Neoplasm - blood Antineoplastic Combined Chemotherapy Protocols - therapeutic use Biomarkers, Tumor - blood Carcinoembryonic Antigen - blood Carcinoma, Non-Small-Cell Lung - blood Carcinoma, Non-Small-Cell Lung - diagnosis Carcinoma, Non-Small-Cell Lung - drug therapy Disease-Free Survival Female Humans Keratin-19 - blood Lung Neoplasms - blood Lung Neoplasms - diagnosis Lung Neoplasms - drug therapy Male Middle Aged Multivariate Analysis Outcome Assessment (Health Care) - methods Outcome Assessment (Health Care) - statistics & numerical data Pemetrexed - administration & dosage Predictive Value of Tests Prognosis Proportional Hazards Models Retrospective Studies pemetrexed non-squamous non-small cell lung cancer tumor marker Cytokeratin 19 fragment
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!

Be the first to leave a comment!